Newsstand Menu

A new drug for spinal muscular atrophy (SMA)

Print Friendly, PDF & Email

CSHL Professor Adrian Krainer has developed a new drug for spinal muscular atrophy (SMA), a devastating neuromuscular disease, in collaboration with California-based Ionis Pharmaceuticals. The drug is currently in Phase I clinical trials.